BD

Franklin Lakes, United States Founded: 1897 • Age: 129 yrs Listed
BD is recognized for providing innovative medical technology solutions.

About BD

BD is a publicly listed company based in Franklin Lakes (United States) founded in 1897. BD is recognized for providing innovative medical technology solutions. It operates on a Direct-to-Consumer (D2C) and Professional Services model. The company has 74,000 employees. BD has completed 36 acquisitions, including ATTO Technology, Accuri Cytometers and Alverix. Its chief executive, as recorded, is Tom Polen. Its website bd.com draws about 1.2 million monthly visits. BD offers products and services including BD Vacutainer UltraTouch and BD ChloraPrep. Its focus areas include Medical Devices and Diagnostic Equipment. Its legal entity is Becton Dickinson India Private Limited.

Company details

BD, known as Becton Dickinson, is engaged in the development of medical technologies and solutions. The company operates in the healthcare sector, focusing on improving medical discovery, diagnostics, and care delivery. Innovative products and services are offered to enhance safety and efficiency across various healthcare settings. Solutions are designed to support patient care throughout critical life moments, addressing needs in diagnostics and treatment. Operations span globally, with a strong presence in India and other regions.

  • Headquarters Franklin Lakes, United States
  • Employees 74,000
  • Stage Public
  • Sectors
    Healthcare
  • Website category Health
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website bd.com/en-us
  • Social LinkedIn X Facebook YouTube
  • Legal Name Becton, Dickinson And Company
Key Metrics
  • Annual Revenue
    $21.84 B (USD)
    8.24
    as on Sep 30, 2025
  • Net Profit
    $1.68 B (USD)
    -1.58
    as on Sep 30, 2025
  • EBITDA
    $5.69 B (USD)
    8.85
    as on Sep 30, 2025
  • Latest Funding Round
    $336.86K (USD), Grant

    Jan 2021

  • Investors
    HHS

    & 3 more

  • Employee Count
    74,000
  • Investments & Acquisitions

Products & Services of BD

BD offers a comprehensive portfolio of products and services, including BD Vacutainer UltraTouch and BD ChloraPrep.

BD Vacutainer UltraTouch
Medical Devices

Blood collection device ensuring reduced pain during procedure.

BD ChloraPrep
Medical Solutions

Antiseptic solution used for skin preparation before procedures.

Apps and channels of BD

BD publishes 1 mobile app with over 5K+ downloads; its YouTube channel BD has 33.7K subscribers and 30 videos.

BD Infusate Companion
Google Play Medical Everyone Free 5K+ downloads
Developer: BD - Becton Dickinson
View on Google Play
BD
YouTube 33.7K subscribers 30 videos Science & Technology
Open channel

Videos from BD

The most watched videos on BD's YouTube channel, BD (33.7K subscribers). Click a video to play it here.

Listen to Dr. Jeff Andrews talk about extended genotyping and cervical cancer screening
25.1K views
A clinician speaks about the impact testing for vaginitis has on her patients
5.3K views
Kylee Johnson, CNM, WHNP-BC talks about HPV self-collection in a healthcare setting
4.9K views
BD Nexiva™ Single Port Closed IV Catheter Insertion Techniques
4.1K views

More on BD.

Funding Insights of BD

  • Total Rounds 6
  • Last Round Grant — $336,864
  • First Round $10.72M

    (Feb 2008)

  • Investors Count 4

All 6 funding rounds of BD with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2021$336,864Grant––
Jul 2020$24MGrant––
Jan 2014Grant––
Feb 2009Grant––
Sep 2008$1.93MGrant––
Feb 2008$10.72MGrant––
Valuation history

4 investors in total: 4 institutional.

Investors in BD

BD has secured backing from 4 investors, including institutional investors. Prominent investors backing the company include HHS, European Union and U.S. Department of Defense.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Public health and human services are overseen by HHS.
1953hhs.gov
Military forces are provided by the U.S. Department of Defense for national security.
defense.govWashington, D.C., United States
Administers health care and support for military personnel and operations.
health.milFalls Church, United States
Premium access

Investor details for BD

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of BD

946 people are tracked at BD (406 in leadership, 13 in board & advisors, 527 in team); the tracked headcount is 74,000.

NameRoleGroup
Tom Polen
CEOLeadership
Meera Gopalakrishnan
SVP & Global CMOLeadership
Jennifer Sipple
Vp, Global Marketing, Medication Management SolutionsLeadership
Manish Ladha
Gm, Software Technology Solutions And Senior Director Of Product ManagementLeadership
Bridget DeLano
Senior Art DirectorLeadership
Lisa Perronne
Senior Director, Division Quality Management, UCCLeadership
Iván Lugo
Vice President APM Global QualityLeadership
Heidi Casaletto
Vp/gm, Global Platform Leader For MicrobiologyLeadership
Kathryn Kelly
VP Of Digital Marketing And Commercial DataLeadership
Kathy Sullivan
VP, Commercial Effectiveness & Marketing OperationsLeadership
Christopher Mogen (C)
Digital Art DirectorLeadership
Wade M.
Associate Director Of Technology And EngineeringLeadership
Steve Gundersen
VP & GM, SCGLeadership
Ankush Rao
Director, Quality ManagementLeadership
Matthew Buraczenski
Director Of Product Security - Secure Technology SolutionsLeadership
Sajid Kunnummal
SVP & Chief Procurement OfficerLeadership
Penny Collins
Vp, Human ResourcesLeadership
Travis Gumbs
Sr. Director Of Microbiology Manufacturing OperationsLeadership
Michael Feld
Executive Vice President, Chief Revenue Officer and President, Life Sciences SegmentLeadership
Jessica Cates Fox
Vp, HR Specimen ManagementLeadership

926 more people are available in the full profile.

Premium access

Complete people profiles for BD

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of BD

BD is a publicly listed company on the NYSE with ticker symbol BDX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date10 May 2020
  • Listed onNYSE: BDXB
  • Listed entityBecton, Dickinson and Company
  • Exchange sectorHealth technology
  • ISINUS0758871091
  • Share price$187.37 (-0.8% on the day) · 2026-10-13
  • Market capitalisation$51.04B
  • Price to earnings56.5
  • EPS (diluted, trailing year)$3.32
  • Dividend yield2.24%
  • Volume (last session)1,153,001

Financials of BD

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
2025$21.84B$1.68B$5.69B
2024$20.18B$1.71B$5.23B
2023$19.37B$1.48B$4.36B
2022$18.87B$1.78B$4.62B
2021$19.13B$2.09B$4.72B
Premium access

Detailed financial statements for BD

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by BD

BD has strategically engaged in corporate development activities, having acquired 36 companies. Notable acquisitions include ATTO Technology, Accuri Cytometers and Alverix.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Web and handheld software is supplied to hospitals and pharmacies.
medkeeper.comDenver, United States2001Jul 2022••••
Automated pharmacy dispensing and adherence packaging solutions are provided.
parata.comDurham, United States2001Jun 2022$1.53B
Flow cytometry reagents, software, and solutions are developed.
cytognos.com1996Feb 2022••••
App for home-based kit enabled urine diagnosis
scanwellhealth.comAnaheim, United States2018Dec 2021••••
Bioadhesive films are developed to seal leaks in surgical procedures.
tissuemed.comLeeds, United Kingdom1985Dec 2021••••
Radiofrequency ablation system for treating venous reflux disease
venclose.comSan Jose, United States2014Dec 2021••••
Diversified contract research organization services are provided to clients.
zebrasci.comTemecula, United States2009Aug 2021••••
Absorbable biomaterials for medical sutures and meshes are developed.
tepha.comLexington, United States1998Jul 2021••••
Provider of a needle-free blood collection device
velanovascular.comSan Francisco, United States2012Jul 2021••••
Medicines dispensing solutions are provided for pharmacies.
gslcorp.comVancouver, Canada2000Mar 2021••••
Premium access

Complete acquisition details for BD

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of BD

14 dated milestones of BD across 125 years, from founding to its latest funding, stage changes and deals.

  1. Founded BD is founded.
  2. Funding First funding round of $10.7M.
  3. IPO Lists on the stock exchange (IPO).
  4. Funding Latest funding round, Grant, of $337K.
  5. Acquisition Acquires GSL Solutions.
  6. Acquisition Acquires Velano Vascular.
  7. Acquisition Acquires Tepha.
  8. Acquisition Acquires ZebraSci.
  9. Acquisition Acquires Venclose.
  10. Acquisition Acquires Tissuemed.
  11. Acquisition Acquires Scanwell Health.
  12. Acquisition Acquires Cytognos.
  13. Acquisition Acquires Parata Systems.
  14. Acquisition Acquires MedKeeper.

Web traffic of BD

The website of BD (bd.com) receives about 1.2M visits a month and ranks #57,463 among all websites worldwide, #1,528 in Health.

  • Monthly visits
    1.2M

    ▲ 16.4% vs previous month

  • Unique visitors
    463.1K

    per month

  • Global rank
    #57,463

    among all websites

  • Category rank
    #1,528

    Health · Health

Similar websites

Websites whose visitors overlap most with BD. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
abbott.com
100%
917.2K#65,577View details
bdj.co.jp
bdj.co.jp
91%
#643,788–
edwards.com
90%
202K#223,603View details
medtronic.com
89%
2.6M#22,622View details
thermofisher.com
85%
5.1M#11,294View details
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 40 similar websites and full traffic analytics for BD

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Traditional Diagnostics & Medical Devices

3 companies that operate in the same segment as BD (Traditional Diagnostics & Medical Devices) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Materials management solutions are provided for healthcare organizations.
1892Chicago, Illinois, United StatesUSD 29.13 MUSD 19.48 B95,424
3D-printed orthopedic products are manufactured for medical applications.
1941Kalamazoo, Michigan, United States
Ophthalmic pharmaceuticals and instruments are developed for eye care.
1853Bridgewater, New Jersey, United StatesUSD 5.1 B13,500
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Bd

Premium access

Complete news archive for BD

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about BD

BD was founded in 1897 and raised its 1st funding round 111 years after it was founded.

BD is headquartered in Franklin Lakes, United States. It is registered at Franklin Lakes, New Jersey, United States.

Tom Polen is the CEO of BD, as recorded in our data.

BD has 74,000 employees.

Annual revenue of BD is $21.84B as on Sep 30, 2025.

BD, known as Becton Dickinson, is engaged in the development of medical technologies and solutions. The company operates in the healthcare sector, focusing on improving medical discovery, diagnostics, and care delivery. Innovative products and services are offered to enhance safety and efficiency across various healthcare settings. Solutions are designed to support patient care throughout critical life moments, addressing needs in diagnostics and treatment. Operations span globally, with a strong presence in India and other regions.

BD offers BD Vacutainer UltraTouch and BD ChloraPrep.

Yes, BD is publicly traded on NYSE under the ticker symbol BDX.

BD has made 36 acquisitions, including ATTO Technology, Accuri Cytometers, and Alverix.

BD has 4 investors. Key investors include HHS, European Union, U.S. Department of Defense, and Military Health.

BD operates through Becton Dickinson India Private Limited.

Yes. BD publishes BD Infusate Companion, with over 5,000 downloads.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available